Enzo Biochem (ENZ) Reports That Its Clinical Labs Division Has Available Newly Authorized Swine Flu (H1N1) Test
1/13/2010 11:29:11 AM
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ) announced today that its Enzo Clinical Labs division has become one of the first diagnostic laboratories to make available a rapid and sensitive H1N1 PCR test for the swine flu virus. Enzo Clinical Labs serves physicians throughout the Metropolitan New York area, as well as New Jersey and parts of Pennsylvania.
comments powered by